Epitope mapping of the anti-CD44 monoclonal antibody (C44Mab-46) using the REMAP method

Teizo Asano, Mika K. Kaneko, Junko Takei, Nami Tateyama, Yukinari Kato

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)


CD44 functions as a major hyaluronan receptor on most cell types, with roles in cell adhesion, migration, proliferation, differentiation, and survival. The CD44 gene comprises 20 exons, with alternative splicing producing many different isoforms. CD44 variant isoforms exhibit tissue-specific expression patterns and have been studied as therapeutic targets for several cancers; therefore, anti-CD44 monoclonal antibodies (mAbs) are useful for investigating CD44 expression in various cancers. Previously, we established an anti-CD44 mAb, C44Mab-46 (IgG1, κ), by immunizing mice with the CD44v3-10 ectodomain. Although C44Mab-46 recognized all CD44 isoforms, the binding epitope of C44Mab-46 has not been determined. In this study, we first checked the reactivity of C44Mab-46 to several CD44v3-10 deletion mutants such as dN79, dN124, dN147, and dN224. We found the N-terminus of the C44Mab-46-binding epitope between residues 147 and 224 of CD44v3-10. We next investigated this epitope using a novel mapping system: RIEDL insertion for epitope mapping (REMAP) method. We constructed 31 CD44 standard (CD44s) mutants where the RIEDL tag was inserted into the expected epitope region in CD44s. We observed that the C44Mab-46 epitope constituted five amino acids: 174-TDDDV-178 of CD44s. Thus, the REMAP method could be used to determine mAb binding epitopes for membrane proteins.

Original languageEnglish
Pages (from-to)156-161
Number of pages6
JournalMonoclonal Antibodies in Immunodiagnosis and Immunotherapy
Issue number4
Publication statusPublished - 2021 Aug 1


  • CD44
  • epitope mapping
  • monoclonal antibody
  • REMAP method


Dive into the research topics of 'Epitope mapping of the anti-CD44 monoclonal antibody (C44Mab-46) using the REMAP method'. Together they form a unique fingerprint.

Cite this